Venus Medtech (Hangzhou) Inc. (HKG:2500)
1.225
+0.055 (4.70%)
Sep 11, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of 536.42 million as of September 11, 2026. Its market cap has decreased by -68.65% in one year.
Market Cap
536.42M
Enterprise Value
688.12M
Revenue
294.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.23
ChartMarket Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 16.91B to 536.42M, a decrease of -96.83%. That is a compound annual growth rate of -39.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 536.42M | -48.53% |
| Dec 31, 2025 | 1.04B | -83.31% |
| Dec 30, 2022 | 6.24B | -51.82% |
| Dec 31, 2021 | 12.96B | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai HeartCare Medical Technology Corporation | 1.83B |
| Acotec Scientific Holdings | 1.81B |
| MicroPort CardioFlow Medtech | 1.63B |
| Sisram Medical | 929.66M |
| Cryofocus Medtech (Shanghai) | 679.06M |
| Gaush Meditech | 664.04M |
| Vincent Medical Holdings | 442.27M |
| Austar Lifesciences | 374.18M |